PDF) 3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 1: Diagnosis and Medical Management
Inflammatory Bowel Disease (IBD)
Palle BAGER | Clinical Nurse Specialist / Senior researcher / Associate Professor at Aarhus University | RN, MPH, PhD | Aarhus University Hospital, Århus | AUH | Department of Hepatology and Gastroenterology
Editorial_Board | Journal of Crohn's and Colitis | Oxford Academic
A continued story of success: Feeding science, digesting knowledge
PDF) Budesonide is superior to mesalazine in maintaining disease remission for patients with steroid-dependent Crohn's disease | Gerassimos Mantzaris - Academia.edu
ECCO in Vienna was the Best Congress Ever!
PDF) The histopathological approach to inflammatory bowel disease: A practice guide
Γεράσιμος Μάντζαρης: «Ύφεση νόσου με ασφαλή και αποτελεσματικά φάρμακα» - Hellenic Medical Review
Clinical profiles of moderate and severe Crohn's disease patients and use of anti-tumor necrosis factor agents: Greek expert consensus guidelines. - Abstract - Europe PMC
PDF) P621 Real-world effectiveness and safety of vedolizumab and anti-TNF in biologic-naive Crohn's disease patients: results from the EVOLVE study
Vedolizumab and Anti-Tumour Necrosis Factor α Real-World Outcomes in Biologic-Naïve Inflammatory Bowel Disease Patients: Resul
European Crohn´s and Colitis Organisation - ECCO - The Council of National Representatives
Inflammatory Bowel Diseases
PDF) Oral azathioprine for steroid refractory severe ulcerative colitis | Gerassimos Mantzaris - Academia.edu
European Crohn´s and Colitis Organisation - ECCO - The Council of National Representatives
John TRIANTAFILLIDIS | Inflammatory Bowel Disease Unit, IASO General Hospital, Athens, Greece | Associate Professor, University of Medicine and Pharmacy, Iasi, Romania | IASO Hospital, Athens, Athens | IASO | IBD unit
NewsWINTER
Tibor HLAVATY | Senior gastroenterologist | MD, PhD, Assoc. Prof | Department of internal medicine V. | Research profile
Editorial_Board | Journal of Crohn's and Colitis | Oxford Academic
Editorial_Board | Journal of Crohn's and Colitis | Oxford Academic
Editorial_Board | Journal of Crohn's and Colitis | Oxford Academic
ECCO Position Statement on the Use of Biosimilars for Inflammatory Bowel Disease—An Update
Editorial_Board | Journal of Crohn's and Colitis | Oxford Academic
ECCO
iBDNEWS#1/14
